Study of Isoquercetin (IQC-950AN) Plus Standard of Care Versus Standard of Care Only for the Treatment of COVID-19
Stopped Never started
Conditions
Interventions
- DRUG: Isoquercetin (IQC-950AN)
Sponsor
Institut de Recherches Cliniques de Montreal
Collaborators
- [object Object]
- [object Object]
- [object Object]